New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
05:55 EDTRPRX, RPRX, RPRX, RPRX, RPRXRepros Therapeutics management to meet with Roth Capital
Meetings to be held in Dallas on February 25, in San Francisco on February 26, in Boston on February 27 and in New York on February 28 hosted by Roth Capital.
News For RPRX From The Last 14 Days
Check below for free stories on RPRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 26, 2014
11:12 EDTRPRXHigh option volume stocks
Subscribe for More Information
August 22, 2014
11:05 EDTRPRXPiper Jaffray biopharm analyst holds an analyst/industry conference call
Subscribe for More Information
09:01 EDTRPRXRepros Therapeutics has favorable near-term catalysts, says BofA/Merrill
BofA/Merrill lowered Repros Therapeutics' price target to $27 from $32 due to competitive pricing and a contraction in the TRT market but says it expects favorable near-term data from Androxal and AndroGel studies. The firm expects the Sept 17 FDA meeting to access DV risks from exogenous testosterone to be favorable. Shares are Buy rated.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use